A0A2J8NKJ9 (A0A2J8NKJ9_PANTR) Pan troglodytes (Chimpanzee)
Gamma-aminobutyric acid receptor subunit alpha-1 UniProtKBInterProInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Cryo-EM structure of the human synaptic alpha1-beta3-gamma2 GABAA receptor in complex with Megabody… |
Heteromer P14867; P18507; P28472; | 2×NAG; 3×NAG; 1×NAG; 1×NAG; 3×POV; 2×PIO; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 6×PTY; 1×Q3G; 1×A8W; | ||||
| Assess | ||||||
| Complex of GABA-A synaptic receptor with autoimmune antibody Fab115 |
Heteromer P14867; P18507; P47870; | 4×NAG; 2×NAG; 1×NAG; | ||||
| Assess | ||||||
| Complex of GABA-A synaptic receptor with autoimmune antibody Fab175 |
Heteromer P14867; P18507; P47870; | 3×NAG; 2×NAG; 1×NAG; 2×ABU; 2×NAG; 1×MAN; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×V8D; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone s… |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×ZWY; 6×PTY; 1×Q3G; 1×POV; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 2×PFL; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 1×RI5; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 4×DZP; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide |
Heteromer P14867; P18507; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×J94; 1×MAN; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA |
Heteromer P14867; P18507; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital |
Heteromer P14867; P18507; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 2×UQA; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil |
Heteromer P14867; P18507; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 1×FYP; | ||||
| Assess | ||||||
| Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P18507; P47870; | 2×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 12×Y01; 1×FYP; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×Y4B; 2×ABU; | ||||
| Assess | ||||||
| Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation… |
Heteromer P14867; P18507; P47870; | 2×NAG; 1×NAG; 1×NAG; 3×NAG; 2×ABU; 12×Y01; 1×FYP; | ||||
| Assess | ||||||
| Cryo-EM structure of human full-length synaptic alpha1beta3gamma2 GABA(A)R in complex with Ro15-451… |
Heteromer P14867; P18507; P28472; | 1×NAG; 2×NAG; 2×NAG; 1×NAG; 2×PIO; 1×OCT; 4×D10; 3×CL; 1×NAG; 1×EIE; | ||||
| Assess | ||||||
| a1b3 GABA-A receptor + GABA |
Heteromer P14867; P28472; | 2×NAG; 3×NAG; 2×ABU; 3×NAG; 1×HSM; | ||||
| Assess | ||||||
| GABA-A receptor bound by a-Cobratoxin |
Heteromer P01391; P14867; P28472; | 1×NAG; 1×NAG; 1×NAG; 1×NAG; 4×NAG; 1×HSM; 1×ZN; 1×HEX; | ||||
| Assess | ||||||
| a1b3 GABA-A receptor + GABA + Zn2+ |
Heteromer P14867; P28472; | 3×NAG; 1×NAG; 2×NAG; 2×NAG; 2×UND; 2×OCT; 4×HEX; 2×ABU; 1×ZN; 1×HSM; 3×D10; | ||||
| Assess | ||||||
| CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with diazepam (Valium)… |
Heteromer P14867; P18507; P28472; | 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×PIO; 2×ABU; 3×DZP; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus Zolpidem |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 3×R5R; 2×ABU; | ||||
| Assess | ||||||
| Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus DMCM |
Heteromer P14867; P18507; P47870; | 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×ABU; 3×R63; | ||||
| Assess | ||||||
| Crystal structure of an apo chimeric human alpha1GABAA receptor | homo-5-mer | |||||
| Assess | ||||||
| Crystal structure of a chimeric human alpha1GABAA receptor in complex with alphaxalone | homo-5-mer | 5×EY4; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8foi.1.A | monomer | 0.73 | 1×D12; 3×OCT; | 98.68 | ||
| Assess | ||||||